Israel Healthcare Ventures
Israel Healthcare Ventures (IHCV)[1] - Isaac Kaye is a founding member of the IHCV which was created in 2001 (through Isaac Kaye Family Trust). Harvey Kruger, Steven Kaye and Warren Roiter are also reported to be founding members[2].
The IHCV describes itself as 'a venture capital fund dedicated to providing venture capital investment to Israeli life sciences companies'[3]. It's headquarters is in Tel Aviv, Israel.
In 2003, it is reported that IHCV purchased a 14% stake in XTL Biopharmaceuticals Ltd (XTLbio), a biopharmaceutical company formed in 1993 which develops drugs to treat hepatitis[4]
People
References
- ↑ Hebrew University of Jerusalem Isaac Kaye Accessed 9th April 2008
- ↑ Company News Feed formerly Regulatory News Service 'XTL Biopharm Ltd - XTLbio Announces Purchase of 14% Stake by IHCV'. 17th July 2003
- ↑ Israel Healthcare Ventures Home Page Accessed 9th April 2008
- ↑ Company News Feed formerly Regulatory News Service 'XTL Biopharm Ltd - XTLbio Announces Purchase of 14% Stake by IHCV'. 17th July 2003
- ↑ Company News Feed formerly Regulatory News Service 'XTL Biopharm Ltd - XTLbio Announces Purchase of 14% Stake by IHCV'. 17th July 2003
